2018 Journal Article Immunosuppression is associated with clinical features and relapse risk of B cell posttransplant lymphoproliferative disorder: a retrospective analysis based on the prospective, international, multicenter PTLD-1 trialsZimmermann, Heiner, Babel, Nina, Dierickx, Daan, Morschhauser, Franck, Mollee, Peter, Zaucha, Jan M., Dreyling, Martin H., Dührsen, Ulrich, Reinke, Petra, Verhoef, Gregor, Subklewe, Marion, Hüttmann, Andreas, Tousseyn, Thomas, Bachy, Emmanuel, Hauser, Ingeborg A., Tarella, Corrado, Van Den Neste, Eric, Gheysens, Olivier, Anagnostopoulos, Ioannis, Leblond, Veronique, Riess, Hanno, Choquet, Sylvain and Trappe, Ralf U. (2018). Immunosuppression is associated with clinical features and relapse risk of B cell posttransplant lymphoproliferative disorder: a retrospective analysis based on the prospective, international, multicenter PTLD-1 trials. Transplantation, 102 (11), 1914-1923. doi: 10.1097/TP.0000000000002269 |
2018 Journal Article Pomalidomide – author replyScott, Ashleigh P. and Mollee, Peter (2018). Pomalidomide – author reply. Leukemia and Lymphoma, 60 (4), 1-1. doi: 10.1080/10428194.2018.1516884 |
2018 Journal Article Relative survival of patients with lymphoma in Queensland according to histological subtypeWright, Fraser, Hapgood, Greg, Loganathan, Aravi, Dunn, Nathan, Philpot, Shoni, Moore, Julie and Mollee, Peter (2018). Relative survival of patients with lymphoma in Queensland according to histological subtype. Medical Journal of Australia, 209 (4), 166-172. doi: 10.5694/mja17.00937 |
2018 Journal Article Considerations for pre-transfusion immunohaematology testing in patients receiving the anti-CD38 monoclonal antibody daratumumab for the treatment of multiple myelomaQuach, Hang, Benson, Simon, Haysom, Helen, Wilkes, Anne-Marie, Zacher, Nicole, Cole-Sinclair, Merrole, Miles Prince, Henry, Mollee, Peter, Spencer, Andrew, Joy Ho, Phoebe, Harrison, Simon J, Lee, Cindy, Augustson, Bradley and Daly, James (2018). Considerations for pre-transfusion immunohaematology testing in patients receiving the anti-CD38 monoclonal antibody daratumumab for the treatment of multiple myeloma. Internal Medicine Journal, 48 (2), 210-220. doi: 10.1111/imj.13707 |
2017 Journal Article A global call to arms for clinical laboratories - Harmonised quantification and reporting of monoclonal proteinsTate, Jillian R., Keren, David F. and Mollee, Peter (2017). A global call to arms for clinical laboratories - Harmonised quantification and reporting of monoclonal proteins. Clinical Biochemistry, 51, 4-9. doi: 10.1016/j.clinbiochem.2017.11.009 |
2017 Journal Article The treatment of paraprotein-related kidney diseaseHutchison, Colin A., Xiong, Fei and Mollee, Peter (2017). The treatment of paraprotein-related kidney disease. Current Opinion in Nephrology and Hypertension, 26 (6), 477-483. doi: 10.1097/MNH.0000000000000369 |
2017 Journal Article ‘Real-world’ Australian experience of pomalidomide for relapsed and refractory myelomaScott, Ashleigh, Weber, Nicholas, Tiley, Campbell, Taylor, Kerry, Taper, John, Harrison, Simon, Chan, Kah-Lok, Stark, Richard, Lee, Cindy, Morris, Kirk, Ho, P. Joy, Dodds, Anthony, Ramanathan, Sundra, Ramakrishna, Raj, Watson, Anne-Marie, Auguston, Bradley, Kwok, Fiona, Quach, Hang, Warburton, Pauline, Rowlings, Philip and Mollee, Peter (2017). ‘Real-world’ Australian experience of pomalidomide for relapsed and refractory myeloma. Leukemia and Lymphoma, 59 (6), 1514-1516. doi: 10.1080/10428194.2017.1387911 |
2017 Journal Article Bisphosphonate guidelines for treatment and prevention of myeloma bone diseaseLee, Oi Lin, Horvath, Noemi, Lee, Cindy, Joshua, Doug, Ho, Joy, Szer, Jeff, Quach, Hang, Spencer, Andrew, Harrison, Simon, Mollee, Peter, Roberts, Andrew W., Talaulikar, Dipti, Brown, Ross, Augustson, Bradley, Ling, Silvia, Jaksic, Wilfrid, Gibson, John, Kalff, Anna, Johnston, Anna, Kalro, Akash, Ward, Chris, Prince, H. Miles and Zannettino, Andrew (2017). Bisphosphonate guidelines for treatment and prevention of myeloma bone disease. Internal Medicine Journal, 47 (8), 938-951. doi: 10.1111/imj.13502 |
2017 Journal Article The duality of macrophage function in Chronic Lymphocytic LeukaemiaChen, Y. C. E., Mapp, S., Blumenthal, A., Burgess, M. L., Mazzieri, R., Mattarollo, S., Mollee, P., Gill, D. and Saunders, N. A. (2017). The duality of macrophage function in Chronic Lymphocytic Leukaemia. Biochimica et Biophysica Acta (BBA) Reviews on Cancer, 1868 (1), 176-182. doi: 10.1016/j.bbcan.2017.03.006 |
2017 Journal Article Monitoring of light chain myeloma - time for a changeMollee, Peter and Tate, Jill (2017). Monitoring of light chain myeloma - time for a change. British Journal of Haematology, 178 (2), 177-178. doi: 10.1111/bjh.14752 |
2017 Journal Article Using pharmacy management systems for research: survival outcomes for lenalidomide in multiple myeloma in the clinical settingSharkey, Megan M., McKavanagh, Daniel, Walpole, Euan, Mollee, Peter and Hollingworth, Samantha A. (2017). Using pharmacy management systems for research: survival outcomes for lenalidomide in multiple myeloma in the clinical setting. International Journal of Clinical Pharmacy, 39 (4), 836-843. doi: 10.1007/s11096-017-0480-0 |
2017 Journal Article Peripherally InSerted CEntral catheter dressing and securement in patients with cancer: the PISCES trial. Protocol for a 2x2 factorial, superiority randomised controlled trialRickard, Claire M., Marsh, Nicole M., Webster, Joan, Gavin, Nicole C., Chan, Raymond J., McCarthy, Alexandra L., Mollee, Peter, Ullman, Amanda J., Kleidon, Tricia, Chopra, Vineet, Zhang, Li, McGrail, Matthew R., Larsen, Emily, Abu Choudhury, Md, Keogh, Samantha, Alexandrou, Evan, McMillan, David J., Mervin, Merehau Cindy, Paterson, David L., Cooke, Marie, Ray-Barruel, Gillian, Castillo, Maria Isabel, Hallahan, Andrew, Corley, Amanda and Playford, E. Geoffrey (2017). Peripherally InSerted CEntral catheter dressing and securement in patients with cancer: the PISCES trial. Protocol for a 2x2 factorial, superiority randomised controlled trial. BMJ Open, 7 (6) e015291, e015291. doi: 10.1136/bmjopen-2016-015291 |
2017 Journal Article Mass spectrometry analysis for amyloidosis typing - is the future bright for its clinical implementation?Hill, Michelle M. and Mollee, Peter N. (2017). Mass spectrometry analysis for amyloidosis typing - is the future bright for its clinical implementation?. Expert Review of Proteomics, 14 (7), 565-566. doi: 10.1080/14789450.2017.1322905 |
2017 Journal Article Partial response after induction chemotherapy has clinical relevance in acute myeloid leukaemiaFleming, Shaun, Ong, Doen Ming, Jackson, Kathryn, Avery, Sharon, Mollee, Peter, Marlton, Paula, Kennedy, Glen and Wei, Andrew H (2017). Partial response after induction chemotherapy has clinical relevance in acute myeloid leukaemia. British Journal of Haematology, 177 (2), 328-330. doi: 10.1111/bjh.14063 |
2017 Journal Article Malabsorption secondary to gout-induced amyloidosisAzzam, Ali, Balasubramaniam, Renuka, Safa, Shahram, McIvor, Carolyn and Mollee, Peter (2017). Malabsorption secondary to gout-induced amyloidosis. ACG Case Reports Journal, 4 (1), e32. doi: 10.14309/crj.2017.32 |
2017 Journal Article Response to rituximab induction is a predictive marker in B-cell post-transplant lymphoproliferative disorder and allows successful stratification into rituximab or r-chop consolidation in an international, prospective, multicenter Phase II trialTrappe, Ralf U., Dierickx, Daan, Zimmermann, Heiner, Morschhauser, Franck, Mollee, Peter, Zaucha, Jan M., Dreyling, Martin H., Duhrsen, Ulrich, Reinke, Petra, Verhoef, Gregor, Subklewe, Marion, Huttmann, Andreas, Tousseyn, Thomas, Salles, Gilles, Kliem, Volker, Hauser, Ingeborg A., Tarella, Corrado, Neste, Eric Van Den, Gheysens, Olivier, Anagnostopoulos, Ioannis, Leblond, Veronique, Riess, Hanno and Choquet, Sylvain (2017). Response to rituximab induction is a predictive marker in B-cell post-transplant lymphoproliferative disorder and allows successful stratification into rituximab or r-chop consolidation in an international, prospective, multicenter Phase II trial. Journal of Clinical Oncology, 35 (5), 536-543. doi: 10.1200/JCO.2016.69.3564 |
2017 Journal Article Monoclonal gammopathy of renal significance triggering atypical haemolytic uraemic syndrome : MGRS triggering aHUSMahmood, Usman, Isbel, Nicole, Mollee, Peter, Mallett, Andrew, Govindarajulu, Sridevi and Francis, Ross (2017). Monoclonal gammopathy of renal significance triggering atypical haemolytic uraemic syndrome : MGRS triggering aHUS. Nephrology, 22 (S1), 15-17. doi: 10.1111/nep.12934 |
2017 Journal Article Treatment of patients with Waldenström macroglobulinaemia: clinical practice guidelines from the Myeloma Foundation of Australia Medical and Scientific Advisory GroupTalaulikar, Dipti, Tam, Constantine S., Joshua, Douglas, Ho, Joy Phoebe, Szer, Jeff, Quach, Hang, Spencer, Andrew, Harrison, Simon, Mollee, Peter, Roberts, Andrew W., Horvath, Noemi, Lee, Cindy, Zannettino, Andrew, Brown, Ross, Augustson, Bradley, Jaksic, Wilfrid, Gibson, John, Kalff, Anna, Johnston, Anna, Trotman, Judith, Kalro, Akash, Grigoriadis, George, Ward, Chris and Prince, H. Miles (2017). Treatment of patients with Waldenström macroglobulinaemia: clinical practice guidelines from the Myeloma Foundation of Australia Medical and Scientific Advisory Group. Internal Medicine Journal, 47 (1), 35-49. doi: 10.1111/imj.13311 |
2016 Journal Article Design and development of the Australian and New Zealand (ANZ) myeloma and related diseases registryBergin, Krystal, Moore, Elizabeth, McQuilten, Zoe, Wood, Erica, Augustson, Bradley, Blacklock, Hilary, Ho, Joy, Horvath, Noemi, King, Tracy, McNeil, John, Mollee, Peter, Quach, Hang, Reid, Christopher M., Rosengarten, Brian, Walker, Patricia and Spencer, Andrew (2016). Design and development of the Australian and New Zealand (ANZ) myeloma and related diseases registry. Bmc Medical Research Methodology, 16 (1) 151, 151. doi: 10.1186/s12874-016-0250-z |
2016 Journal Article The utility of 99mTc-DPD scintigraphy in the diagnosis of cardiac amyloidosis: an Australian experienceMoore, Peter T., Burrage, Matthew K., Mackenzie, Emily, Law, W. Philip, Korczyk, Dariusz and Mollee, Peter (2016). The utility of 99mTc-DPD scintigraphy in the diagnosis of cardiac amyloidosis: an Australian experience. Heart, Lung and Circulation, 26 (11), 1183-1190. doi: 10.1016/j.hlc.2016.12.017 |